COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey
Autor
Fecha
2023-01Enlace permanente
https://hdl.handle.net/11351/8994DOI
10.1007/s00296-022-05229-7
ISSN
1437-160X
WOS
000871168700001
PMID
36271958
Palabras clave
COVID-19; Miopatías inflamatorias idiopáticas; Vacunación SARS-CoV-2Citación recomendada
Hoff LS, Ravichandran N, Shinjo SK, Day J, Sen P, Junior JG, et al. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Disease. Rheumatol Int. 2023 Jan;43:47–58.
Audiencia
Professionals
Este elemento aparece en las siguientes colecciones
- Col·lecció especial COVID-19 [945]
- HVH - Articles científics [4476]
El ítem tiene asociados los siguientes ficheros de licencia:





